(Q36056192)

11 August 2017

Clinical value of CD24 expression in retinoblastoma (English)

1 reference

11 August 2017

1 reference

Jia Li

1

1 reference

11 August 2017

Changqing Li

series ordinal

2

1 reference

11 August 2017

Hongfeng Yuan

series ordinal

3

1 reference

11 August 2017

Fang Gong

series ordinal

4

1 reference

11 August 2017

14 June 2012

1 reference

Journal of Biomedicine and Biotechnology

11 August 2017

1 reference

11 August 2017

2012

1 reference

11 August 2017

158084

1 reference

Creative Commons Attribution 3.0 Unported

11 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of BART through interaction with G3BP.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

CD24 overexpression in cancer development and progression: a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

Expression of alpha-crystallin in retinoblastoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic target

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

Glycomic analysis of N-linked carbohydrate epitopes from CD24 of mouse brain

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3382394

O-glycosylation pattern of CD24 from mouse brain

11 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2012%2F158084

Loss of CD24 expression promotes ductal branching in the murine mammary gland

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2012%2F158084

CD24 overexpression in cancer development and progression: A meta-analysis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2012%2F158084

CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification

21 January 2018

1 reference

12 December 2020

Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas

1 reference

12 December 2020

Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract

1 reference

12 December 2020

CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance

1 reference

12 December 2020

Clinico-pathological correlations of fatty acid synthase expression in retinoblastoma: an Indian cohort study

1 reference

12 December 2020

Clinicopathologic and prognostic significance of CD24 in gallbladder carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/158084

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22745528

1 reference